 |
 |
|
|
|
| Adapalene |
 |
| 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
 |
| 106685-40-9 |
 |
| Adapalene is one of a series of stable retinoid analogues, developed by Galderma. It is a selective retinoic acid receptor agonist and its mode of action involves the normalization of differentiation of follicular epithelial cells, resulting in reduced microcomedone formation. |
 |
Items Specification
Description White to off-white crystalline powder
Related Impurity (HPLC) Single impurity: NMT 0.5%
Total impurity: NMT 1.0%
Assay NLT 99.0%
Residue on Ignition NMT 0.1%
|
|
|
|
|
|
